This is the authors' abstract. We don't add key points for this paper.
We report here a mild process to access diversely functionalized enantioenriched β‐ gem ‐difluorinated ( S )‐alcohols by using biocatalytic reduction in >99% yield and enantiomeric excesses ranging from 96% to >99%. This novel approach involves enzymatic reduction of α‐ gem ‐difluorinated heterocyclic and carbocyclic ketone derivatives as well as an acyclic gem ‐difluorinated β‐ketosulfone and proceeds under mild conditions at 30 °C under aqueous conditions to produce a range of high added value enantioenriched difluorinated alcohols including 3,3‐difluorochromanol, 3,3‐difluorothiochromanol, 3,3‐difluoro‐dihydroquinolinol, and α‐difluorinated β‐hydroxysulfone derivatives. A comparative study between enzymatic reduction and metal‐catalyzed asymmetric transfer hydrogenation was carried out as well.
No takes yet. Share an insight, caveat, or question.
Bacheley et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: